Stimulating a hormone does not guarantee that a compound reproduces every effect of administering that hormone directly. This mouse study tested the distinction for body fat. Primary study
Reported comparisons
The investigators compared ipamorelin and growth hormone in growth-hormone-deficient and hormone-intact mice. Ipamorelin increased relative fat-pad measures, and secretagogue exposure increased measured relative body fat in additional experiments. Feeding and leptin findings differed from direct growth-hormone treatment. The authors proposed growth-hormone-independent contributions, potentially including increased food intake. Primary report
Our appraisal: test the net outcome
A mechanistic expectation about lipolysis cannot substitute for measuring total body composition. Appetite, intake, energy expenditure, tissue partitioning, and endocrine effects can act simultaneously. The net phenotype is an empirical question.
The hormone-deficient model helps interrogate dependence on the growth-hormone axis, but it is not identical to an otherwise healthy animal with one pathway temporarily blocked. Genetic background and developmental adaptation may affect the response. Cross-model comparisons should retain those differences.
Increased feeding is a plausible contributor, not automatically a complete explanation. Pair-feeding or a suitably designed mediation experiment would more directly test how much of the adiposity change depends on intake. Leptin changes likewise should not be treated as proof of a particular causal direction.
Relative fat measures must be read alongside absolute quantities and body-weight changes. A ratio can change because of its numerator, denominator, or both. The full data are needed to characterize the phenotype accurately.
This study does not establish that ipamorelin increases fat in humans. It does, however, undermine a simplistic inference that growth-hormone release necessarily means fat loss. It is a preclinical counterexample that belongs in a balanced evidence record rather than being omitted from promotional summaries.
Frequently asked questions
Was this a human body-composition trial?
No.
Did ipamorelin simply match direct growth-hormone effects?
No.
Were hormone-deficient animals included?
Yes.
Was increased feeding a proposed contributor?
Yes.
Does a feeding association prove complete mediation?
No.
Can relative fat measures be interpreted without body weight?
Not adequately.
What assumption does the report challenge?
That stimulating growth-hormone release automatically produces fat loss.